CI
Price
$270.51
Change
+$2.56 (+0.96%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
71.83B
27 days until earnings call
Intraday BUY SELL Signals
CLOV
Price
$4.38
Change
+$0.15 (+3.55%)
Updated
Oct 2 closing price
Capitalization
2.3B
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CI vs CLOV

CI vs CLOV Comparison Chart in %
View a ticker or compare two or three
VS
CI vs. CLOV commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Hold and CLOV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CI vs CLOV: Fundamental Ratings
CI
CLOV
OUTLOOK RATING
1..100
5675
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
5492
PRICE GROWTH RATING
1..100
5537
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CI's Valuation (5) in the Managed Health Care industry is in the same range as CLOV (36) in the null industry. This means that CI’s stock grew similarly to CLOV’s over the last 12 months.

CI's Profit vs Risk Rating (61) in the Managed Health Care industry is somewhat better than the same rating for CLOV (100) in the null industry. This means that CI’s stock grew somewhat faster than CLOV’s over the last 12 months.

CI's SMR Rating (54) in the Managed Health Care industry is somewhat better than the same rating for CLOV (92) in the null industry. This means that CI’s stock grew somewhat faster than CLOV’s over the last 12 months.

CLOV's Price Growth Rating (37) in the null industry is in the same range as CI (55) in the Managed Health Care industry. This means that CLOV’s stock grew similarly to CI’s over the last 12 months.

CI's P/E Growth Rating (74) in the Managed Health Care industry is in the same range as CLOV (100) in the null industry. This means that CI’s stock grew similarly to CLOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CICLOV
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 23 days ago
63%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CI: $270.53 vs. CLOV: $4.38)
Brand notoriety: CI: Notable vs. CLOV: Not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CI: 114% vs. CLOV: 105%
Market capitalization -- CI: $71.83B vs. CLOV: $2.3B
CI [@Managed Health Care] is valued at $71.83B. CLOV’s [@Managed Health Care] market capitalization is $2.3B. The market cap for tickers in the [@Managed Health Care] industry ranges from $335.99K to $339.14B. The average market capitalization across the [@Managed Health Care] industry is $64.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CI’s FA Score shows that 1 FA rating(s) are green while CLOV’s FA Score has 0 green FA rating(s).

  • CI’s FA Score: 1 green, 4 red.
  • CLOV’s FA Score: 0 green, 5 red.
According to our system of comparison, CLOV is a better buy in the long-term than CI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CI’s TA Score shows that 3 TA indicator(s) are bullish while CLOV’s TA Score has 4 bullish TA indicator(s).

  • CI’s TA Score: 3 bullish, 6 bearish.
  • CLOV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CI and CLOV are a bad buy in the short-term.

Price Growth

CI (@Managed Health Care) experienced а -0.54% price change this week, while CLOV (@Managed Health Care) price change was -2.45% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -0.95%. For the same industry, the average monthly price growth was -7.58%, and the average quarterly price growth was +57.17%.

Reported Earning Dates

CI is expected to report earnings on Oct 29, 2026.

CLOV is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Managed Health Care (-0.95% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

View a ticker or compare two or three
CI
Daily Signal:
Gain/Loss:
CLOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RUM7.640.08
+1.06%
RUM Group Inc
TOVX0.22N/A
N/A
Theriva Biologics Inc
SPEG10.42N/A
N/A
Silver Pegasus Acquisition Corp
INMD14.05-0.12
-0.85%
InMode Ltd
KVUE17.22-0.44
-2.49%
Kenvue

CI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CI
1D Price
Change %
CI100%
-1.42%
CVS - CI
50%
Loosely correlated
-0.57%
ELV - CI
46%
Loosely correlated
-1.84%
CNC - CI
40%
Loosely correlated
-1.82%
HUM - CI
38%
Loosely correlated
-0.50%
UNH - CI
36%
Loosely correlated
-0.51%
More

CLOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLOV has been loosely correlated with HUM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CLOV jumps, then HUM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
-1.86%
HUM - CLOV
39%
Loosely correlated
-0.50%
ALHC - CLOV
37%
Loosely correlated
-5.15%
OSCR - CLOV
31%
Poorly correlated
-3.05%
UNH - CLOV
30%
Poorly correlated
-0.51%
CI - CLOV
24%
Poorly correlated
-1.42%
More